DNMT3A mutations have also been reported in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML), and myeloproliferative neoplasms (MPN) [38]. This evidence concerns the gene DNMT3A and myeloproliferative disorder.